Mercedes Herrera-Juarez Selected Research

Anemia

1/2023

ONCOS-102 plus pemetrexed and platinum chemotherapy in malignant pleural mesothelioma: a randomized phase 2 study investigating clinical outcomes and the tumor microenvironment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mercedes Herrera-Juarez Research Topics

Disease

1	Malignant Mesothelioma 01/2023
1	Anemia 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Neutropenia 01/2023
1	Testicular Neoplasms (Testicular Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

1	Pemetrexed (MTA)FDA Link 01/2023
1	AntigensIBA 01/2023
1	PlatinumIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2023
1	Therapeutics 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023